Immune Checkpoint Inhibitor Therapy and Risk of Glomerular Disease: A Large Propensity-Matched Cohort Study.

Tsai PH, Chang WC, Jhou HJ, Chen HY, Kao LT, Hsieh TY, Chen PH, Lee CH

Open source

DOI
10.3390/life16091576
Published
2026 Sep 21
Container
Life (Basel, Switzerland)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/life16091576,
  title = {Immune Checkpoint Inhibitor Therapy and Risk of Glomerular Disease: A Large Propensity-Matched Cohort Study.},
  author = {Tsai PH and Chang WC and Jhou HJ and Chen HY and Kao LT and Hsieh TY and Chen PH and Lee CH},
  year = {2026},
  journal = {Life (Basel, Switzerland)},
  doi = {10.3390/life16091576},
  url = {https://doi.org/10.3390/life16091576}
}

RIS

TY  - JOUR
TI  - Immune Checkpoint Inhibitor Therapy and Risk of Glomerular Disease: A Large Propensity-Matched Cohort Study.
AU  - Tsai PH
AU  - Chang WC
AU  - Jhou HJ
AU  - Chen HY
AU  - Kao LT
AU  - Hsieh TY
AU  - Chen PH
AU  - Lee CH
PY  - 2026
JO  - Life (Basel, Switzerland)
DO  - 10.3390/life16091576
UR  - https://doi.org/10.3390/life16091576
ER  - 

APA

PH, T., WC, C., HJ, J., HY, C., LT, K., TY, H., PH, C., & CH, L. (2026). Immune Checkpoint Inhibitor Therapy and Risk of Glomerular Disease: A Large Propensity-Matched Cohort Study.. Life (Basel, Switzerland). https://doi.org/10.3390/life16091576

Source records